Global Intravenous (IV) Solution Market Insights, Forecast to 2025

Publisher Name :
Date: 14-May-2019
No. of pages: 119
Inquire Before Buying

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.

Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

The global Intravenous (IV) Solution market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Solution market based on company, product type, end user and key regions.

This report studies the global market size of Intravenous (IV) Solution in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous (IV) Solution in these regions.

This research report categorizes the global Intravenous (IV) Solution market by top players/brands, region, type and end user. This report also studies the global Intravenous (IV) Solution market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- ICU Medical

- B. Braun Melsungen

- Fresenius Kabi

- Baxter

- Amanta Healthcare

- Terumo Medical Corporation

- Grifols

Market size by Product

- by Product Type

- - Total Parenteral Solution

- - Peripheral Parenteral Solution

- by Nutritional Content

- - Amino Acid Solution

- - Carbohydrates

- - Vitamins & Minerals

- - Parenteral Lipid Emulsion

- - Others

Market size by End User

- Hospitals & Clinics

- Ambulatory

- Homecare

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Intravenous (IV) Solution market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Intravenous (IV) Solution market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Intravenous (IV) Solution companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Intravenous (IV) Solution submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intravenous (IV) Solution are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous (IV) Solution market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Intravenous (IV) Solution Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Intravenous (IV) Solution Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravenous (IV) Solution Market Size Growth Rate by Product
1.4.2 Total Parenteral Solution
1.4.3 Peripheral Parenteral Solution
1.5 Market by End User
1.5.1 Global Intravenous (IV) Solution Market Size Growth Rate by End User
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous (IV) Solution Market Size
2.1.1 Global Intravenous (IV) Solution Revenue 2014-2025
2.1.2 Global Intravenous (IV) Solution Sales 2014-2025
2.2 Intravenous (IV) Solution Growth Rate by Regions
2.2.1 Global Intravenous (IV) Solution Sales by Regions
2.2.2 Global Intravenous (IV) Solution Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.2 Intravenous (IV) Solution Sales Market Share by Manufacturers
3.1.3 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous (IV) Solution Revenue by Manufacturers
3.2.1 Intravenous (IV) Solution Revenue by Manufacturers (2014-2019)
3.2.2 Intravenous (IV) Solution Revenue Share by Manufacturers (2014-2019)
3.3 Intravenous (IV) Solution Price by Manufacturers
3.4 Intravenous (IV) Solution Manufacturing Base Distribution, Product Types
3.4.1 Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous (IV) Solution Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Solution Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Intravenous (IV) Solution Sales by Product
4.2 Global Intravenous (IV) Solution Revenue by Product
4.3 Intravenous (IV) Solution Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Intravenous (IV) Solution Breakdown Data by End User
6 North America
6.1 North America Intravenous (IV) Solution by Countries
6.1.1 North America Intravenous (IV) Solution Sales by Countries
6.1.2 North America Intravenous (IV) Solution Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intravenous (IV) Solution by Product
6.3 North America Intravenous (IV) Solution by End User
7 Europe
7.1 Europe Intravenous (IV) Solution by Countries
7.1.1 Europe Intravenous (IV) Solution Sales by Countries
7.1.2 Europe Intravenous (IV) Solution Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous (IV) Solution by Product
7.3 Europe Intravenous (IV) Solution by End User
8 Asia Pacific
8.1 Asia Pacific Intravenous (IV) Solution by Countries
8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Countries
8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Intravenous (IV) Solution by Product
8.3 Asia Pacific Intravenous (IV) Solution by End User
9 Central & South America
9.1 Central & South America Intravenous (IV) Solution by Countries
9.1.1 Central & South America Intravenous (IV) Solution Sales by Countries
9.1.2 Central & South America Intravenous (IV) Solution Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Intravenous (IV) Solution by Product
9.3 Central & South America Intravenous (IV) Solution by End User
10 Middle East and Africa
10.1 Middle East and Africa Intravenous (IV) Solution by Countries
10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Countries
10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intravenous (IV) Solution by Product
10.3 Middle East and Africa Intravenous (IV) Solution by End User
11 Company Profiles
11.1 ICU Medical
11.1.1 ICU Medical Company Details
11.1.2 Company Business Overview
11.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.1.4 ICU Medical Intravenous (IV) Solution Products Offered
11.1.5 ICU Medical Recent Development
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Company Details
11.2.2 Company Business Overview
11.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.2.4 B. Braun Melsungen Intravenous (IV) Solution Products Offered
11.2.5 B. Braun Melsungen Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Company Business Overview
11.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Fresenius Kabi Intravenous (IV) Solution Products Offered
11.3.5 Fresenius Kabi Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Company Business Overview
11.4.3 Baxter Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Baxter Intravenous (IV) Solution Products Offered
11.4.5 Baxter Recent Development
11.5 Amanta Healthcare
11.5.1 Amanta Healthcare Company Details
11.5.2 Company Business Overview
11.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Amanta Healthcare Intravenous (IV) Solution Products Offered
11.5.5 Amanta Healthcare Recent Development
11.6 Terumo Medical Corporation
11.6.1 Terumo Medical Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Terumo Medical Corporation Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Terumo Medical Corporation Intravenous (IV) Solution Products Offered
11.6.5 Terumo Medical Corporation Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Company Business Overview
11.7.3 Grifols Intravenous (IV) Solution Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Grifols Intravenous (IV) Solution Products Offered
11.7.5 Grifols Recent Development
12 Future Forecast
12.1 Intravenous (IV) Solution Market Forecast by Regions
12.1.1 Global Intravenous (IV) Solution Sales Forecast by Regions 2019-2025
12.1.2 Global Intravenous (IV) Solution Revenue Forecast by Regions 2019-2025
12.2 Intravenous (IV) Solution Market Forecast by Product
12.2.1 Global Intravenous (IV) Solution Sales Forecast by Product 2019-2025
12.2.2 Global Intravenous (IV) Solution Revenue Forecast by Product 2019-2025
12.3 Intravenous (IV) Solution Market Forecast by End User
12.4 North America Intravenous (IV) Solution Forecast
12.5 Europe Intravenous (IV) Solution Forecast
12.6 Asia Pacific Intravenous (IV) Solution Forecast
12.7 Central & South America Intravenous (IV) Solution Forecast
12.8 Middle East and Africa Intravenous (IV) Solution Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravenous (IV) Solution Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Intravenous (IV) Solution Product Picture
Table Intravenous (IV) Solution Market Segments
Table Key Manufacturers Intravenous (IV) Solution Covered
Table Global Intravenous (IV) Solution Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Intravenous (IV) Solution Sales Market Share by Product 2014-2025
Figure Total Parenteral Solution Product Picture
Table Major Manufacturers of Total Parenteral Solution
Figure Peripheral Parenteral Solution Product Picture
Table Major Manufacturers of Peripheral Parenteral Solution
Table Global Intravenous (IV) Solution Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals & Clinics
Figure Ambulatory
Figure Homecare
Figure Intravenous (IV) Solution Report Years Considered
Figure Global Intravenous (IV) Solution Market Size 2014-2025 (Million US$)
Figure Global Intravenous (IV) Solution Sales 2014-2025 (K Units)
Table Global Intravenous (IV) Solution Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Intravenous (IV) Solution Sales by Regions 2014-2019 (K Units)
Table Global Intravenous (IV) Solution Sales Market Share by Regions 2014-2019
Figure Global Intravenous (IV) Solution Sales Market Share by Regions 2014-2019
Figure 2018 Global Intravenous (IV) Solution Sales Market Share by Regions
Table Global Intravenous (IV) Solution Revenue by Regions 2014-2019 (Million US$)
Table Global Intravenous (IV) Solution Revenue Market Share by Regions 2014-2019
Figure Global Intravenous (IV) Solution Revenue Market Share by Regions 2014-2019
Figure 2018 Global Intravenous (IV) Solution Revenue Market Share by Regions
Table Global Intravenous (IV) Solution Sales by Manufacturers (2014-2019) (K Units)
Table Global Intravenous (IV) Solution Sales Share by Manufacturers (2014-2019)
Figure Global Intravenous (IV) Solution Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Intravenous (IV) Solution Revenue by Manufacturers (2014-2019) (Million USD)
Table Intravenous (IV) Solution Revenue Share by Manufacturers (2014-2019)
Figure Intravenous (IV) Solution Value Share by Manufacturers in 2018
Table Key Manufacturers Intravenous (IV) Solution Price (2014-2019) (USD/Unit)
Table Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Intravenous (IV) Solution Product Type
Table Date of International Manufacturers Enter into Intravenous (IV) Solution Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table Global Intravenous (IV) Solution Sales Share by Product (2014-2019)
Figure Global Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure Global Intravenous (IV) Solution Sales Market Share by Product in 2018
Table Global Intravenous (IV) Solution Revenue by Product (2014-2019) (Million US$)
Table Global Intravenous (IV) Solution Revenue Share by Product (2014-2019)
Figure Global Intravenous (IV) Solution Revenue Market Share by Product (2014-2019)
Figure Global Intravenous (IV) Solution Revenue Market Share by Product in 2018
Table Intravenous (IV) Solution Price by Product 2014-2019 (USD/Unit)
Table Global Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table Global Intravenous (IV) Solution Sales Share by End User (2014-2019)
Figure Global Sales Intravenous (IV) Solution Market Share by End User (2014-2019)
Figure Global Sales Intravenous (IV) Solution Market Share by End User in 2018
Figure North America Intravenous (IV) Solution Sales Growth Rate 2014-2019 (K Units)
Figure North America Intravenous (IV) Solution Revenue Growth Rate 2014-2019 (Million US$)
Table North America Intravenous (IV) Solution Sales by Countries (2014-2019) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Countries (2014-2019)
Figure 2018 North America Intravenous (IV) Solution Sales Market Share by Countries
Table North America Intravenous (IV) Solution Revenue by Countries (2014-2019) (Million US$)
Table North America Intravenous (IV) Solution Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Intravenous (IV) Solution Revenue Market Share by Countries
Figure United States Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure United States Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Canada Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Table North America Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure 2018 North America Intravenous (IV) Solution Market Share by Product
Table North America Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by End User (2014-2019)
Figure 2018 North America Intravenous (IV) Solution Market Share by End User
Figure Europe Intravenous (IV) Solution Sales Growth Rate 2014-2019 (K Units)
Figure Europe Intravenous (IV) Solution Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Intravenous (IV) Solution Sales by Countries (2014-2019) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Intravenous (IV) Solution Sales Market Share by Countries
Table Europe Intravenous (IV) Solution Revenue by Countries (2014-2019) (Million US$)
Table Europe Intravenous (IV) Solution Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Intravenous (IV) Solution Revenue Market Share by Countries
Figure Germany Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Germany Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure France Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure France Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure UK Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Italy Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Russia Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure 2018 Europe Intravenous (IV) Solution Market Share by Product
Table Europe Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by End User (2014-2019)
Figure 2018 Europe Intravenous (IV) Solution Market Share by End User
Figure Asia Pacific Intravenous (IV) Solution Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Intravenous (IV) Solution Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Intravenous (IV) Solution Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Intravenous (IV) Solution Sales Market Share by Countries
Table Asia Pacific Intravenous (IV) Solution Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Intravenous (IV) Solution Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Intravenous (IV) Solution Revenue Market Share by Countries
Figure China Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure China Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Japan Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Korea Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure India Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure India Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Australia Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Intravenous (IV) Solution Market Share by Product
Table Asia Pacific Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Intravenous (IV) Solution Market Share by End User
Figure Central & South America Intravenous (IV) Solution Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Intravenous (IV) Solution Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Intravenous (IV) Solution Sales by Countries (2014-2019) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Intravenous (IV) Solution Sales Market Share by Countries
Table Central & South America Intravenous (IV) Solution Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Intravenous (IV) Solution Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Intravenous (IV) Solution Revenue Market Share by Countries
Figure Brazil Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Intravenous (IV) Solution Market Share by Product
Table Central & South America Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Intravenous (IV) Solution Market Share by End User
Figure Middle East and Africa Intravenous (IV) Solution Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Intravenous (IV) Solution Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Intravenous (IV) Solution Sales Market Share by Countries
Table Middle East and Africa Intravenous (IV) Solution Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries
Figure GCC Countries Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Intravenous (IV) Solution Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Intravenous (IV) Solution Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Intravenous (IV) Solution Market Share by Product
Table Middle East and Africa Intravenous (IV) Solution Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Intravenous (IV) Solution Market Share by End User
Table ICU Medical Company Details
Table ICU Medical Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ICU Medical Recent Development
Table B. Braun Melsungen Company Details
Table B. Braun Melsungen Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table B. Braun Melsungen Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius Kabi Recent Development
Table Baxter Company Details
Table Baxter Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Recent Development
Table Amanta Healthcare Company Details
Table Amanta Healthcare Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amanta Healthcare Recent Development
Table Terumo Medical Corporation Company Details
Table Terumo Medical Corporation Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Terumo Medical Corporation Recent Development
Table Grifols Company Details
Table Grifols Intravenous (IV) Solution Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Grifols Recent Development
Table Global Intravenous (IV) Solution Sales Forecast by Regions 2019-2025 (K Units)
Table Global Intravenous (IV) Solution Sales Market Share Forecast by Regions 2019-2025
Table Global Intravenous (IV) Solution Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Intravenous (IV) Solution Revenue Market Share Forecast by Regions 2019-2025
Table Global Intravenous (IV) Solution Sales Forecast by Product 2019-2025 (K Units)
Table Global Intravenous (IV) Solution Sales Market Share Forecast by Product 2019-2025
Table Global Intravenous (IV) Solution Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Intravenous (IV) Solution Revenue Market Share Forecast by Product 2019-2025
Table Global Intravenous (IV) Solution Sales Forecast by End User 2019-2025 (K Units)
Table Global Intravenous (IV) Solution Sales Market Share Forecast by End User 2019-2025
Figure North America Intravenous (IV) Solution Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Intravenous (IV) Solution Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Intravenous (IV) Solution Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Intravenous (IV) Solution Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Intravenous (IV) Solution Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Intravenous (IV) Solution Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Intravenous (IV) Solution Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Intravenous (IV) Solution Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Intravenous (IV) Solution Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Intravenous (IV) Solution Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Intravenous (IV) Solution Value Chain
Table Intravenous (IV) Solution Customers List
Table Intravenous (IV) Solution Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs